Conference Coverage: American College of Rheumatology (ACR): Annual Scientific Meeting

Conference Coverage

Novel agent found to benefit Sjögren’s patients

SAN DIEGO – Multiple doses of the investigational agent CFZ533 administered for 24 weeks in patients with primary Sjögren’s syndrome were safe and...

Pages